Molecular basis for Epstein-Barr virus genome DNA replication

EB 病毒基因组 DNA 复制的分子基础

基本信息

项目摘要

Productive infection/replication of herpesviruses usually occurs in growth arrested cells but there has been no direct evidence in case of Epstein-Barr virus (EBV) since an efficient lytic replication system without external stimuli does not exist for the virus. Expression of EBV lytic switch transactivator BZLF1 protein in EBV-negative epithelial tumor cell lines, however, is known to arrest cell cycle in G0/G1 by induction of the tumor suppressor protein, p53 and the cyclin dependent kinase inhibitors, p21WAF-1/CIP-1 and p27KIP-1 followed by the accumulation of hypophosphorylated form of Rb protein. In order to determine the effect of onset of the lytic viral replication on cellular events in EBV-latently infected B lymphoblastoid cell lines, a tightly controlled induction system of the EBV lytic replication program by inducible BZLF1 protein expression was established in B95-8 cells. The induction of the lytic replication completely arrested cell cycle progression and cellular DNA replication. Surprisingly, the levels of p53, p21WAF-1/CIP-1, and p27KIP-1 were constant before and after the lytic program induction, indicating that the cell cycle arrest induced by the lytic program is not mediated through p53 and the CDK inhibitors. Furthermore, although cellular DNA replication was blocked, elevation of cyclin E/A expression and accumulation of hyperphosphorylated forms of Rb protein were observed, being a post-G1/S phase characteristics of cells. Thus, while the EBV lytic program promoted specific cell cycle associated activities involved in the progression from G1 to S phase, it inhibited cellular DNA synthesis. Such cellular condition appears to most favors viral lytic replication.
疱疹病毒的生产性感染/复制通常发生在生长受阻的细胞中,但由于没有外部刺激的有效裂解复制系统,因此没有直接证据表明eb病毒(EBV)。然而,在EBV阴性上皮肿瘤细胞系中,EBV裂解开关反激活因子BZLF1蛋白的表达,已知通过诱导肿瘤抑制蛋白p53和周期蛋白依赖性激酶抑制剂p21WAF-1/CIP-1和p27KIP-1,然后积累低磷酸化形式的Rb蛋白,在G0/G1期阻滞细胞周期。为了确定裂解病毒开始复制对EBV潜伏感染的B淋巴母细胞样细胞系细胞事件的影响,在B95-8细胞中建立了一个通过诱导表达BZLF1蛋白来严格控制EBV裂解复制程序的诱导系统。裂解复制的诱导完全阻止了细胞周期的进展和细胞DNA的复制。令人惊讶的是,在裂解程序诱导前后,p53、p21WAF-1/CIP-1和p27KIP-1的水平是恒定的,这表明裂解程序诱导的细胞周期阻滞不是通过p53和CDK抑制剂介导的。此外,尽管细胞DNA复制被阻断,但观察到细胞周期蛋白E/A表达升高和Rb蛋白过度磷酸化形式的积累,这是细胞g1 /S期后的特征。因此,虽然EBV裂解程序促进了从G1期到S期的特定细胞周期相关活动,但它抑制了细胞DNA合成。这种细胞状态似乎最有利于病毒裂解复制。

项目成果

期刊论文数量(74)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Fujita M: "Nuclear organization of DNA replication initiation proteins in mammalian cells"J.Biol.Chem.. 277. 10354-10361 (2002)
Fujita M:“哺乳动物细胞中 DNA 复制起始蛋白的核组织”J.Biol.Chem.. 277. 10354-10361 (2002)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Fujita M: "Nuclear organization of DNA replication initiation proteins in mammalian cells"J.Biol.Chem.. (in press). (2002)
Fujita M:“哺乳动物细胞中 DNA 复制起始蛋白的核组织”J.Biol.Chem..(出版中)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Fujii K. et al: "The Epstein-Barr virus Pol catalytic subunit physically interacts with the BBLF4-BSLF1-BBLF2/3 complex."Journal of Virology. 74. 2550-2557 (2000)
Fujii K. 等人:“Epstein-Barr 病毒 Pol 催化亚基与 BBLF4-BSLF1-BBLF2/3 复合物发生物理相互作用。”病毒学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hoshino Y. et al: "Early intervention in post-transplant lymphoproliferative dosorders based on Eqstein-Barr riral load."Bone Marrow Transplant. 26. 199-202 (2000)
Hoshino Y. 等人:“基于 Eqstein-Barr 病毒负荷对移植后淋巴细胞增殖剂量顺序进行早期干预。”骨髓移植。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TSURUMI tatsuya其他文献

TSURUMI tatsuya的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Exploiting Metabolism to Uncloak Epstein-Barr Virus Immunogens in Latently Infected B-cells
利用代谢揭示潜伏感染 B 细胞中的 Epstein-Barr 病毒免疫原
  • 批准号:
    10889325
  • 财政年份:
    2023
  • 资助金额:
    $ 5.38万
  • 项目类别:
Epstein-Barr Virus nuclear antigen leader protein in transcription regulation
Epstein-Barr病毒核抗原前导蛋白在转录调控中的作用
  • 批准号:
    10829620
  • 财政年份:
    2023
  • 资助金额:
    $ 5.38万
  • 项目类别:
Project 4 - Controlling the Latent-to-Lytic Switch in Epstein-Barr Virus
项目 4 - 控制 Epstein-Barr 病毒中的潜伏至裂解转换
  • 批准号:
    10910338
  • 财政年份:
    2023
  • 资助金额:
    $ 5.38万
  • 项目类别:
Understanding the immune response changes to clinical interventions for Epstein-Barr virus infection prior to lymphoma development in children after organ transplants (UNEARTH)
了解器官移植后儿童淋巴瘤发展之前针对 Epstein-Barr 病毒感染的临床干预的免疫反应变化(UNEARTH)
  • 批准号:
    10755205
  • 财政年份:
    2023
  • 资助金额:
    $ 5.38万
  • 项目类别:
Regulation and Functions of the Epstein-Barr Virus Lytic Switch Protein
EB 病毒裂解开关蛋白的调控和功能
  • 批准号:
    489085
  • 财政年份:
    2023
  • 资助金额:
    $ 5.38万
  • 项目类别:
    Operating Grants
Characterization of Epstein-Barr Virus Subversion of the Host SMC5/6 Restriction Pathway
Epstein-Barr 病毒颠覆宿主 SMC5/6 限制途径的特征
  • 批准号:
    10679118
  • 财政年份:
    2023
  • 资助金额:
    $ 5.38万
  • 项目类别:
Epstein Barr Virus Driven Mechanisms of Post Transplant Lymphoproliferative Disease
EB 病毒驱动的移植后淋巴增殖性疾病的机制
  • 批准号:
    10755055
  • 财政年份:
    2023
  • 资助金额:
    $ 5.38万
  • 项目类别:
Deciphering the Role of Epstein-Barr Virus Molecular Mimicry and B cell Transformation in Multiple Sclerosis
解读 Epstein-Barr 病毒分子拟态和 B 细胞转化在多发性硬化症中的作用
  • 批准号:
    10568864
  • 财政年份:
    2023
  • 资助金额:
    $ 5.38万
  • 项目类别:
Project 2: Novel investigation of Epstein-Barr virus as a potential cause of conjunctival squamous cell carcinoma among people living with HIV in Zimbabwe
项目 2:对 Epstein-Barr 病毒作为津巴布韦艾滋病毒感染者结膜鳞状细胞癌潜在原因的新调查
  • 批准号:
    10598376
  • 财政年份:
    2023
  • 资助金额:
    $ 5.38万
  • 项目类别:
Project 3 - Characterizing the Amplification Factories of Epstein-Barr Virus and Kaposi's Sarcoma-associated Herpesvirus
项目 3 - 描述 Epstein-Barr 病毒和卡波西肉瘤相关疱疹病毒的扩增工厂
  • 批准号:
    10910337
  • 财政年份:
    2023
  • 资助金额:
    $ 5.38万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了